Pain Management Devices Market by Application, Product and Geography - Forecast and analysis- 2023-2027

Published: Oct 2023 Pages: 165 SKU: IRTNTR75682

Pain Management Devices Market Forecast 2023-2027

The pain management devices market size is forecast to increase by USD 2.71 billion, at a CAGR of 8.92% between 2022 and 2027.  The growth of the market for drug-free therapy relies on various factors, notably the rising incidence of chronic diseases among the geriatric population. With a shift towards non-pharmacological approaches, there's a surge in demand for alternative treatments. Moreover, the healthcare industry is witnessing numerous initiatives and advancements, fostering a conducive environment for market expansion. These developments underscore the importance of drug-free therapies in managing chronic conditions, offering effective solutions with minimal side effects. As the population ages and chronic diseases become more prevalent, the demand for such therapies is expected to rise, driving further growth in the market.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, View Report Sample

Market Segmentation

This market report extensively covers market segmentation by application (neuropathic pain, musculoskeletal disorder, cancer, facial and migraine, and others), product (neurostimulation devices, infusion pumps, and ablation devices), and geography (North America, Asia, Europe, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

Market Dynamics and Customer Landscape 

The market experiences growth driven by various factors such as the increasing prevalence of chronic pain conditions like musculoskeletal pain and cancer pain, prompting a demand surge for innovative solutions. Technological advancements, particularly in neuromodulation and neurostimulation devices, offer promising alternatives for pain relief. However, challenges persist, including limited consumer awareness and the need for enhanced rehabilitation services. Moreover, catering to diverse patient demographics such as elderly populations and those with cardiovascular disease poses unique challenges. Overcoming these hurdles while capitalizing on emerging trends remains crucial for the sustained growth of the market. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Market Driver

The increasing prevalence of chronic diseases among the geriatric population is the key driver for the growth of the market share. The prevalence of chronic diseases is rising among the geriatric population due to declining mortality rates. The sedentary lifestyle and changing eating habits of people make them favorable for chronic diseases such as heart disease, stroke, cancer, arthritis, and chronic pain such as low back pain and knee pain.  According to the CDC and the National Center for Health Statistics (NCHS), most people with chronic pain have pain in different body parts.

In addition, the American Academy of Pain Medicine (AAPM), in the US, has seen the most common types of pain among adults are low back pain at 28.1%, knee pain at 19.5%, shoulder pain at 9.0%, finger pain at 7.6%, and hip pain at 7.1%. According to the Centers for disease control and Prevention (CDC), approximately 11% of the adult population of the US suffers from chronic pain. Pain management devices are used to treat chronic diseases. Therefore, the increasing prevalence of chronic diseases and the growth of the geriatric population will drive the growth of the market during the forecast period

Key Market Trends

Technological advances in ablation devices is the primary trend in the market growth. The ablation method is used used to reduce certain kinds of chronic pain by preventing the transmission of pain signals. Technological advances in ablation have improved the outcomes of various procedures. With ablation devices, a portion of nerve tissue is removed or destroyed to cause an interruption in pain signals and reduce pain in that area. Vendors are increasing their focus on such advances to increase their market share.

Moreover, vendors are making significant investments in (R&D) to develop technologically advanced ablation devices. For example, Medtronic offers the Cool-tip radiofrequency (RF) ablation system E series, which has high energy and creates large ablation target zones in a short period of time. The high adoption of irrigated-tip ablation catheters has reduced the risk of complications and ensured the precise removal of arrhythmia-promoting heart cells. Therefore, the increasing adoption of such technologically advanced ablation devices for pain management will drive the growth of the market during the forecast period.

Key Market Challenge

The high cost of neurostimulation devices and procedures is the key challenge in the market. The high cost of neurostimulation devices limits their adoption in several developing countries such as India and China. The cost of deep brain stimulation (DBS) surgeries can range between USD 70,000 and USD 100,000 for bilateral procedures.  End-users also pay additional costs to maintain these devices, make post-operative device adjustments, and replace the batteries regularly. For example, the cost of battery replacement for DBS therapy can be USD 10,000- USD 20,000 during the first 36 months after implantation. In addition, vendors price their neurostimulation devices high owing to structural barriers to competition, such as the complex and expensive regulatory approval process and patent protection.

Furthermore, insurance coverage for novel neurostimulation therapies is limited. Medicare stopped covering TENS for lower back pain. Organizations such as the NHS believe that scientific proof to state that TENS is a reliable and effective method of pain relief is limited. Many private insurers also do not provide reimbursement coverage for neurostimulation devices owing to the lack of sufficient data on clinical effectiveness. Hence, the lack of insurance coverage restricts patient access to neurostimulation therapies, which is expected to hinder the growth of the market growth and trends during the forecast period.

Market Customer Landscape

The market research report includes the adoption lifecycle of the market research and growth, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market analysis and report also include key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.

customer Landscape

Who are the Major Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Abbott Laboratories: The company offers pain management devices such as Proclaim SCS system.

The research report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

  • AtriCure Inc.
  • Avanos Medical Inc.
  • B.Braun SE
  • Baxter International Inc.
  • Becton Dickinson and Co.
  • Boston Scientific Corp.
  • DJO Global Inc.
  • ICU Medical Inc.
  • InfuTronix
  • Johnson and Johnson Services Inc.
  • Kimberly Clark Corp.
  • Medtronic Plc
  • Micrel Medical Devices SA
  • Moog Inc.
  • Nevro Corp.
  • OMRON Corp.
  • Pfizer Inc.
  • Stryker Corp.
  • Theragen Inc.

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Largest-Growing Segments in the Market?

Chronic pain patients rely on pain management devices to alleviate discomfort and enhance their quality of life. These devices cater to various types of pain, including acute pain, cancer pain, and musculoskeletal pain, offering targeted relief through innovative technologies. Analgesic infusion pumps and spinal cord stimulators are among the advanced devices used, providing effective pain control and improving patient outcomes. Increased consumer awareness drives demand, leading to greater adoption in physiotherapy centers, rehabilitation facilities, and hospitals. Neuromodulation and neurostimulation devices are pivotal for managing pain in conditions like cardiovascular disease, cancer, stroke, and among the elderly population suffering from osteoarthritis. These devices revolutionize pain management, offering hope and comfort to millions worldwide.

The neuropathic pain segment is estimated to witness significant growth during the forecast period. The neuropathic pain segment accounts for the highest share in the market due to the increasing target population, technological advancements in pain management devices, and a surge in demand for pain management devices for treating neuropathic pain. Neuropathic pain is a complex, chronic pain condition that happens by tissue injury. The impact of nerve fiber injury creates a change in nerve function at the site of injury and areas surrounding the injury.

Get a glance at the market contribution of various segments View the PDF Sample

The neuropathic pain segment was the largest segment and was valued at  USD 1.15 billion in 2017. In the US, according to the Centers for Disease Control and Prevention (CDC), 84.10 million people had prediabetes symptoms. In 2022, 50% of patients with diabetes had nerve pain problems. Hence, an increase in the prevalence of neuropathic pain will drive the growth of the neuropathic pain segment of the global neuropathy pain treatment market during the forecast period.

Which are the Key Regions for the Market?

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional market trends and analysis, and drivers that shape the market during the forecast period. Owing to the growing prevalence of chronic diseases, such as diabetes, cancer, and arthritis, among others North America shows the largest share of the market in 2022. In addition, the increasing geriatric population; growing technological advances that enable the development of innovative devices; and rising healthcare expenditure drive the growth of the market in focus in this region. The rapid growth of the market in North America is due to the high prevalence of chronic disorders, the presence of favourable reimbursement policies, and the presence of established vendors. 

Moreover, the presence of prominent vendors in the market in North America is expected to propel the growth of the market in this region. Companies such as Becton, Dickinson, Chemyx Inc. (Chemyx), Flowonix Medical, and Baxter International are prominent players in the market, which have a major presence in North America. These companies are focusing on the development of advanced and innovative pain management devices which are majorly used in home-care settings as well as hospitals for pain management.

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Application Outlook
    • Neuropathic pain
    • Musculoskeletal disorder
    • Cancer
    • Facial and migraine
    • Others
  • Product Outlook 
    • Neurostimulation devices
    • Infusion pumps
    • Ablation devices
  • Region Outlook 
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Australia
      • Argentina
      • Rest of the world

Market Analyst Overview

The market addresses the growing challenge of lifestyle related diseases and neuropathic disorders, offering advanced solutions to alleviate suffering. With increasing healthcare awareness, patients seek relief from conditions such as skin hypersensitivity, hyperpigmentation, and chronic ailments. Innovative spinal cord stimulation devices and radiofrequency (RF) ablation devices target refractory pain, providing effective alternatives to pharmaceutical medications and injury prevention. These devices utilize electrical stimulation to target nerves and offer relief from conditions like cardiovascular disorders, atrial fibrillation, and rheumatoid arthritis. Deployed in hospitals and clinics, they cater to cancer patients, stroke patients, and those with orthopedic degenerative disorders, addressing a spectrum of facial and migraine pain.

Market Scope

Report Coverage

Details

Page number

165

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 8.92%

Market growth 2023-2027

USD 2.71 billion 

Market structure

Fragmented

YoY growth 2022-2023(%)

7.56

Regional analysis

North America, Asia, Europe, and Rest of World (ROW)

Performing market contribution

North America at 44%

Key countries

US, Germany, UK, China, and Japan

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, AtriCure Inc., Avanos Medical Inc., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Boston Scientific Corp., DJO Global Inc., ICU Medical Inc., InfuTronix, Johnson and Johnson Services Inc., Kimberly Clark Corp., Medtronic Plc, Micrel Medical Devices SA, Moog Inc., Nevro Corp., OMRON Corp., Pfizer Inc., Stryker Corp., and Theragen Inc.

Market dynamics

Parent market growth analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF Sample

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market between 2023 and 2027
  • Precise estimation of the market  size and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behaviour
  • Growth of the market across North America, Asia, Europe, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of market vendors

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global pain management devices market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global pain management devices market 2017 - 2021 ($ million)
    • 4.2 Application Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ million)
    • 4.3 Product Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Product Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Application

    • 6.1 Market segments
      • Exhibit 30: Chart on Application - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
    • 6.2 Comparison by Application
      • Exhibit 32: Chart on Comparison by Application
      • Exhibit 33: Data Table on Comparison by Application
    • 6.3 Neuropathic pain - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Neuropathic pain - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Neuropathic pain - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Neuropathic pain - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Neuropathic pain - Year-over-year growth 2022-2027 (%)
    • 6.4 Musculoskeletal disorder - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Musculoskeletal disorder - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Musculoskeletal disorder - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Musculoskeletal disorder - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Musculoskeletal disorder - Year-over-year growth 2022-2027 (%)
    • 6.5 Cancer - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Cancer - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Cancer - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Cancer - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
    • 6.6 Facial and migraine - Market size and forecast 2022-2027
      • Exhibit 46: Chart on Facial and migraine - Market size and forecast 2022-2027 ($ million)
      • Exhibit 47: Data Table on Facial and migraine - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Chart on Facial and migraine - Year-over-year growth 2022-2027 (%)
      • Exhibit 49: Data Table on Facial and migraine - Year-over-year growth 2022-2027 (%)
    • 6.7 Others - Market size and forecast 2022-2027
      • Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.8 Market opportunity by Application
      • Exhibit 54: Market opportunity by Application ($ million)
      • Exhibit 55: Data Table on Market opportunity by Application ($ million)

    7 Market Segmentation by Product

    • 7.1 Market segments
      • Exhibit 56: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 57: Data Table on Product - Market share 2022-2027 (%)
    • 7.2 Comparison by Product
      • Exhibit 58: Chart on Comparison by Product
      • Exhibit 59: Data Table on Comparison by Product
    • 7.3 Neurostimulation devices - Market size and forecast 2022-2027
      • Exhibit 60: Chart on Neurostimulation devices - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Data Table on Neurostimulation devices - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Chart on Neurostimulation devices - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on Neurostimulation devices - Year-over-year growth 2022-2027 (%)
    • 7.4 Infusion pumps - Market size and forecast 2022-2027
      • Exhibit 64: Chart on Infusion pumps - Market size and forecast 2022-2027 ($ million)
      • Exhibit 65: Data Table on Infusion pumps - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Chart on Infusion pumps - Year-over-year growth 2022-2027 (%)
      • Exhibit 67: Data Table on Infusion pumps - Year-over-year growth 2022-2027 (%)
    • 7.5 Ablation devices - Market size and forecast 2022-2027
      • Exhibit 68: Chart on Ablation devices - Market size and forecast 2022-2027 ($ million)
      • Exhibit 69: Data Table on Ablation devices - Market size and forecast 2022-2027 ($ million)
      • Exhibit 70: Chart on Ablation devices - Year-over-year growth 2022-2027 (%)
      • Exhibit 71: Data Table on Ablation devices - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by Product
      • Exhibit 72: Market opportunity by Product ($ million)
      • Exhibit 73: Data Table on Market opportunity by Product ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 75: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 76: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 77: Chart on Geographic comparison
      • Exhibit 78: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Asia - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.5 Europe - Market size and forecast 2022-2027
      • Exhibit 87: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 China - Market size and forecast 2022-2027
      • Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.9 Japan - Market size and forecast 2022-2027
      • Exhibit 103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.10 Germany - Market size and forecast 2022-2027
      • Exhibit 107: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 108: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.11 UK - Market size and forecast 2022-2027
      • Exhibit 111: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 112: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 113: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 114: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 115: Market opportunity by geography ($ million)
      • Exhibit 116: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 117: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 119: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 120: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 121: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 122: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 123: Abbott Laboratories - Overview
              • Exhibit 124: Abbott Laboratories - Business segments
              • Exhibit 125: Abbott Laboratories - Key news
              • Exhibit 126: Abbott Laboratories - Key offerings
              • Exhibit 127: Abbott Laboratories - Segment focus
            • 12.4 Avanos Medical Inc.
              • Exhibit 128: Avanos Medical Inc. - Overview
              • Exhibit 129: Avanos Medical Inc. - Business segments
              • Exhibit 130: Avanos Medical Inc. - Key offerings
              • Exhibit 131: Avanos Medical Inc. - Segment focus
            • 12.5 B.Braun SE
              • Exhibit 132: B.Braun SE - Overview
              • Exhibit 133: B.Braun SE - Business segments
              • Exhibit 134: B.Braun SE - Key news
              • Exhibit 135: B.Braun SE - Key offerings
              • Exhibit 136: B.Braun SE - Segment focus
            • 12.6 Baxter International Inc.
              • Exhibit 137: Baxter International Inc. - Overview
              • Exhibit 138: Baxter International Inc. - Business segments
              • Exhibit 139: Baxter International Inc. - Key news
              • Exhibit 140: Baxter International Inc. - Key offerings
              • Exhibit 141: Baxter International Inc. - Segment focus
            • 12.7 Becton Dickinson and Co.
              • Exhibit 142: Becton Dickinson and Co. - Overview
              • Exhibit 143: Becton Dickinson and Co. - Business segments
              • Exhibit 144: Becton Dickinson and Co. - Key news
              • Exhibit 145: Becton Dickinson and Co. - Key offerings
              • Exhibit 146: Becton Dickinson and Co. - Segment focus
            • 12.8 Boston Scientific Corp.
              • Exhibit 147: Boston Scientific Corp. - Overview
              • Exhibit 148: Boston Scientific Corp. - Business segments
              • Exhibit 149: Boston Scientific Corp. - Key news
              • Exhibit 150: Boston Scientific Corp. - Key offerings
              • Exhibit 151: Boston Scientific Corp. - Segment focus
            • 12.9 DJO Global Inc.
              • Exhibit 152: DJO Global Inc. - Overview
              • Exhibit 153: DJO Global Inc. - Product / Service
              • Exhibit 154: DJO Global Inc. - Key offerings
            • 12.10 ICU Medical Inc.
              • Exhibit 155: ICU Medical Inc. - Overview
              • Exhibit 156: ICU Medical Inc. - Product / Service
              • Exhibit 157: ICU Medical Inc. - Key offerings
            • 12.11 Johnson and Johnson Services Inc.
              • Exhibit 158: Johnson and Johnson Services Inc. - Overview
              • Exhibit 159: Johnson and Johnson Services Inc. - Business segments
              • Exhibit 160: Johnson and Johnson Services Inc. - Key news
              • Exhibit 161: Johnson and Johnson Services Inc. - Key offerings
              • Exhibit 162: Johnson and Johnson Services Inc. - Segment focus
            • 12.12 Medtronic Plc
              • Exhibit 163: Medtronic Plc - Overview
              • Exhibit 164: Medtronic Plc - Business segments
              • Exhibit 165: Medtronic Plc - Key news
              • Exhibit 166: Medtronic Plc - Key offerings
              • Exhibit 167: Medtronic Plc - Segment focus
            • 12.13 Moog Inc.
              • Exhibit 168: Moog Inc. - Overview
              • Exhibit 169: Moog Inc. - Business segments
              • Exhibit 170: Moog Inc. - Key offerings
              • Exhibit 171: Moog Inc. - Segment focus
            • 12.14 Nevro Corp.
              • Exhibit 172: Nevro Corp. - Overview
              • Exhibit 173: Nevro Corp. - Product / Service
              • Exhibit 174: Nevro Corp. - Key offerings
            • 12.15 Pfizer Inc.
              • Exhibit 175: Pfizer Inc. - Overview
              • Exhibit 176: Pfizer Inc. - Product / Service
              • Exhibit 177: Pfizer Inc. - Key news
              • Exhibit 178: Pfizer Inc. - Key offerings
            • 12.16 Stryker Corp.
              • Exhibit 179: Stryker Corp. - Overview
              • Exhibit 180: Stryker Corp. - Business segments
              • Exhibit 181: Stryker Corp. - Key news
              • Exhibit 182: Stryker Corp. - Key offerings
              • Exhibit 183: Stryker Corp. - Segment focus
            • 12.17 Theragen Inc.
              • Exhibit 184: Theragen Inc. - Overview
              • Exhibit 185: Theragen Inc. - Product / Service
              • Exhibit 186: Theragen Inc. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 187: Inclusions checklist
                • Exhibit 188: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 189: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 190: Research methodology
                • Exhibit 191: Validation techniques employed for market sizing
                • Exhibit 192: Information sources
              • 13.5 List of abbreviations
                • Exhibit 193: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              pain management devices market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis